Association of Clinical Research Professionals (ACRP) Certified Professional Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ACRP Certified Professional Exam with our comprehensive quiz. Elevate your clinical research skills with targeted flashcards and multiple-choice questions. Enhance your readiness with detailed explanations and insights for improved performance!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What is required before a site can begin enrolling subjects in a phase 3 trial after receiving IRB approval?

Site readiness assessment must be completed
A signed clinical trial agreement between the site and sponsor is in place
Recruitment outreach must be initiated
Investigator must complete all training modules

The correct answer is: A signed clinical trial agreement between the site and sponsor is in place

Before a site can begin enrolling subjects in a phase 3 trial after receiving IRB approval, it is essential to have a signed clinical trial agreement in place between the site and the sponsor. This agreement outlines the responsibilities of both parties, the terms of the study, funding mechanisms, and other legalities. It ensures that both the site and the sponsor are in alignment regarding expectations, contractual obligations, and necessary resources for the trial. Having this agreement finalized is crucial, as it formalizes the collaboration and provides a clear framework for conducting the research. Without it, there may be uncertainties regarding how the study will be supported, the management of any potential liabilities, and how data will be handled or shared. Thus, a signed clinical trial agreement is a fundamental requirement for moving forward with subject enrollment in the trial.